# Karyopharm Therapeutics Inc.: Form 8-K, filed Jul 11, 2025

- Company: [Karyopharm Therapeutics Inc.](/companies/kpti.md) (CIK 1503802)
- Form: 8-K
- Filed: 2025-07-11
- Accepted by EDGAR: Jul 11, 2025, 07:28 ET
- Period: 2025-07-11
- Accession: 0000950170-25-095167
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1503802/000095017025095167/kpti-20250711.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1503802/000095017025095167/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1503802/000095017025095167/kpti-20250711.htm

Filed Jul 11, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-095167. Last ingested by Listed: Nov 5, 2026, 11:51 ET. No prices; not investment advice.